Shionogi & Co., Ltd. (OTCMKTS:SGIOY - Get Free Report) fell 1.1% during trading on Tuesday . The stock traded as low as $8.14 and last traded at $8.30. 52,012 shares changed hands during trading, a decline of 56% from the average session volume of 117,397 shares. The stock had previously closed at $8.39.
Shionogi & Co., Ltd. Price Performance
The company has a current ratio of 7.64, a quick ratio of 7.01 and a debt-to-equity ratio of 0.01. The stock has a market cap of $14.29 billion, a P/E ratio of 13.93, a PEG ratio of 2.37 and a beta of 0.19. The company's 50 day moving average price is $8.02 and its two-hundred day moving average price is $7.49.
Shionogi & Co., Ltd. (OTCMKTS:SGIOY - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.03). The business had revenue of $721.77 million during the quarter, compared to the consensus estimate of $824.23 million. Shionogi & Co., Ltd. had a return on equity of 12.02% and a net margin of 35.53%. Equities analysts forecast that Shionogi & Co., Ltd. will post 0.66 earnings per share for the current year.
About Shionogi & Co., Ltd.
(
Get Free Report)
Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.
See Also
Before you consider Shionogi & Co., Ltd., you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shionogi & Co., Ltd. wasn't on the list.
While Shionogi & Co., Ltd. currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
